Phosphagenics Limited (POH) - Product Pipeline Analysis

Document Sample
Phosphagenics Limited (POH)  - Product Pipeline Analysis Powered By Docstoc
					                              Phosphagenics Limited (POH) - Product Pipeline Analysis

     Reference Code: GDMEPH128930PD                                                                                     Publication Date: NOV 2010



    Company Snapshot                                                         Company Overview
    Key Information
                                                                             Phosphagenics Limited (Phosphagenics), formerly known as Vital
     Phosphagenics Limited, Key Facts                                        Capital Limited, is a biopharmaceutical company. It is principally
                                                                             focuses on the discovery, development and commercialization of
     Web Address                            www.phosphagenics.com
                                                                             pharmaceutical, nutraceutical and cosmeceutical products. The
     Turnover (in USD Million) 1.20                                          company operates its business through two segments, namely,
                                                                             Nutraceuticals and Pharmaceuticals. The Nutraceutical segment is
     Number of Employees                    30                               engaged in developing dietary supplements; functional foods and
     Industry                               Pharmaceuticals and Healthcare   beverages; and personal care products, including skin care products.
     Source:Primary / Secondary Research                                     The company's Pharmaceuticals segment is engaged in drug delivery
     GlobalData                                                              and development.



    Phosphagenics Limited Pipeline Products

      Phosphagenics Limited Key Pipeline Products by Equipment               Phosphagenics Limited Key Pipeline Products by Therapy Area
      Type
     Equipment Type                           No of Products                 Therapy Area                                     No of Products
     Transdermal Drug Delivery                       3                       Chronic pain                                            3
     Insulin Delivery                                1                       Acne                                                    1
     Source: Primary / Secondary Research                                    Diabetes mellitus                                       1
     GlobalData
                                                                             Source: Primary / Secondary Research
                                                                             GlobalData


     Phosphagenics Limited Key Pipeline Products by Equipment Type




     Source: Primary / Secondary Research
     GlobalData




     Phosphagenics Limited Key Pipeline Products by                          Phosphagenics Limited Key Pipeline Products by Trial Phase
     Development Stage
     Developmental Stage                  No of Products                     Trial Phase                                No of Products
     Clinicals                                   5                           Phase IV                                          -
     Pre-Clinicals                                                           Phase III                                         -
                                                 -
     Early development                                                       Phase II                                          -
                                                                 -
     Source: Primary / Secondary Research                                    Phase I                                           1
     GlobalData
     Note : (-) indicates 'Not Available'
                                                                             Source: Primary / Secondary Research
                                                                             GlobalData
                                                                             Note : (-) indicates 'Not Available'




Phosphagenics Limited (POH) - Product Pipeline Analysis                                                                 Reference Code: GDMEPH128930PD

Source : www.globalcompanyintelligence.com                                                                                                           Page 1
    Table of Contents
    Table of Contents................................................................................................................................................................................................................................................................... 2
    List of Tables .......................................................................................................................................................................................................................................................................... 3
    List of Figures......................................................................................................................................................................................................................................................................... 3
    Key Facts ............................................................................................................................................................................................................................................................................... 4
    Phosphagenics Limited - Major Products and Services......................................................................................................................................................................................................... 5
          Phosphagenics Limited Pipeline Products by Equipment Type ...................................................................................................................................................................................... 6
          Phosphagenics Limited Pipeline Products by Development Stage ................................................................................................................................................................................. 8
          Phosphagenics Limited Pipeline Products by Therapy Area ......................................................................................................................................................................................... 10
          Phosphagenics Limited Pipeline Products by Trial Phase ............................................................................................................................................................................................ 12
          Dermal drug delivery system-Retinoic Acid ................................................................................................................................................................................................................... 14
                Product Status......................................................................................................................................................................................................................................................... 14
                Product Description ................................................................................................................................................................................................................................................. 14
          Localized drug delivery system-Diclofenac.................................................................................................................................................................................................................... 14
                Product Status......................................................................................................................................................................................................................................................... 14
                Product Description ................................................................................................................................................................................................................................................. 14
                Product Milestone ................................................................................................................................................................................................................................................... 15
          Localized drug delivery system-Lidocaine ..................................................................................................................................................................................................................... 15
                Product Status......................................................................................................................................................................................................................................................... 15
                Product Description ................................................................................................................................................................................................................................................. 15
                Product Milestone ......................................................................................................................................................
				
DOCUMENT INFO
Description: Phosphagenics Limited (POH) - Product Pipeline Analysis Summary This report is a source for data, analysis and actionable intelligence on the Phosphagenics Limited portfolio of pipeline products. The report provides detailed analysis on each pipeline product with information on the indication, the development stage, trial phase, product milestones, pipeline territory, estimated approval date, and estimated launch date. Each pipeline product is profiled to cover information on product description, function, technology, indication, and application. The report is also supplemented with a detailed company profile and information on clinical trials, wherever applicable. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts. Scope - Detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments. - Detailed coverage on all the pipeline products, by equipment type, by therapy area, by development stage, and by trial phase. - Information on product milestones and pipeline territory for each product, the estimated approval date, and estimated launch date. - Profile of each pipeline product with additional information on product description, function, technology, indication(s), and application. - Data on relevant clinical trials and product patent details, wherever applicable. - Information on clinical trial, wherever applicable, is supplemented with information on trial phase, trial status, trial objective, trial design, target patients, unique physician identifier, primary point, secondary point, acronym, participants inclusion, participants exclusion, interventions, trial results, trial start date, trial end date, study type, trial site, trial funding, age eligibility, and gender eligibility.
BUY THIS DOCUMENT NOW PRICE: $750 100% MONEY BACK GUARANTEED
PARTNER GlobalData
GlobalData is an industry analysis specialist, providing business information products and services. GlobalData’s highly qualified team of analysts, researchers, and solution consultants use proprietary data sources, tools and techniques to gather, analyze and represent the latest and the most reliable information essential for a business to sustain a competitive edge. GlobalData is a UK-based company with presence across North America, Europe and Asia Pacific and has a broad product offering that ranges from interactive databases, reports and custom solutions. It is a comprehensive source of insights and analysis with coverage across the oil & gas, power, alternative energy, nuclear power, petrochemicals, medical equipment and healthcare industries. GlobalData has a broad range of coverage over key market segments. It has a global scope, covering a wide range of countries constituting more than 90% of global revenues in each of the industries it covers. With a large dedicated research and analysis capability, GlobalData employs rigorous primary and secondary research techniques in developing unique data sets and research materials. Its status as an independent research company allows Analysts to conduct trade interviews with key industry players. Access to unique databases of in-house market information further strengthens research and analysis capabilities. Materials are reviewed shaped by an expert panel of leading industry figures and representatives from key players in the relevant industries. Sectors and Geographies Covered GlobalData has a broad range of coverage over key market segments. It has a global scope, covering a wide range of countries constituting more than 90% of global revenues in each of the industries it covers. Research Methodology With a large dedicated research and analysis capability, GlobalData employs rigorous primary and secondary research techniques in developing unique data sets and research materials. Its status as an independent research company allows Analysts to conduct trade interviews with key industry players. Access to unique databases of in-house market information further strengthens research and analysis capabilities. Materials are reviewed shaped by an expert panel of leading industry figures and representatives from key players in the relevant industries.